Profile data is unavailable for this security.
About the company
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
- Revenue in USD (TTM)267.23m
- Net income in USD-83.50m
- Incorporated2020
- Employees1.00k
- LocationGeneDx Holdings Corp333 Ludlow StreetNorth Tower, 8Th FloorSTAMFORD 06902United StatesUSA
- Phone+1 (617) 780-8742
- Fax+1 (302) 636-5454
- Websitehttps://sema4.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pennant Group Inc | 652.30m | 21.15m | 1.16bn | 5.79k | 49.18 | 6.05 | 41.58 | 1.78 | 0.6879 | 0.6879 | 21.25 | 5.59 | 1.12 | -- | 9.10 | 112,640.60 | 3.83 | 1.81 | 4.54 | 2.14 | 20.55 | 21.62 | 3.42 | 1.92 | -- | 4.24 | 0.3676 | 0.00 | 15.14 | 13.76 | 101.40 | -3.13 | 14.07 | -- |
| Pediatrix Medical Group Inc | 2.01bn | -253.84m | 1.37bn | 2.90k | -- | 1.87 | -- | 0.6829 | -3.07 | -3.07 | 24.07 | 8.53 | 0.9116 | -- | 7.11 | 692,068.30 | -11.53 | 0.8579 | -13.80 | 0.9945 | -- | -- | -12.65 | 1.52 | -- | 4.84 | 0.4611 | 0.00 | 1.15 | 2.97 | -196.55 | -- | 14.25 | -- |
| US Physical Therapy Inc | 645.70m | 14.10m | 1.43bn | 3.90k | 101.17 | 2.95 | 29.16 | 2.21 | 0.9352 | 0.9352 | 42.93 | 32.02 | 0.6332 | -- | 8.70 | 165,606.30 | 3.12 | 7.13 | 4.31 | 10.64 | 19.41 | 21.96 | 4.93 | 9.71 | -- | 45.42 | 0.1753 | 58.53 | 9.34 | 5.91 | -38.01 | 1.78 | 5.26 | 13.33 |
| Progyny Inc | 1.13bn | 62.75m | 1.54bn | 563.00 | 27.23 | 3.39 | 23.54 | 1.36 | 0.6266 | 0.6266 | 11.31 | 5.03 | 1.64 | -- | 4.06 | 2,012,426.00 | 9.09 | 11.50 | 13.06 | 16.02 | 22.08 | 21.48 | 5.54 | 6.64 | -- | -- | 0.00 | 0.00 | 38.34 | 59.52 | 104.35 | -- | 44.47 | -- |
| Clover Health Investments Corp | 1.54bn | -95.26m | 1.67bn | 552.00 | -- | 4.87 | -- | 1.08 | -0.1961 | -0.1882 | 3.16 | 0.6839 | 1.80 | -- | 8.38 | 2,797,861.00 | -11.12 | -- | -26.66 | -- | -- | -- | -6.17 | -- | -- | -13.53 | -- | -- | -41.50 | -- | 37.03 | -- | -- | -- |
| Teladoc Health Inc | 2.59bn | -981.73m | 1.69bn | 5.60k | -- | 1.12 | -- | 0.6522 | -5.78 | -5.78 | 15.33 | 8.77 | 0.6592 | 20.73 | 12.39 | 462,430.30 | -24.99 | -33.54 | -30.10 | -34.63 | 70.82 | 68.59 | -37.91 | -171.39 | 1.69 | -- | 0.5055 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
| Astrana Health Inc | 1.59bn | 68.42m | 1.74bn | 1.80k | 32.44 | 3.28 | 19.70 | 1.09 | 1.44 | 1.44 | 33.56 | 14.28 | 1.40 | -- | 9.06 | 884,350.00 | 5.84 | 7.09 | 6.77 | 9.39 | 16.28 | 18.30 | 4.18 | 6.36 | -- | 11.80 | 0.4809 | 10.54 | 21.19 | 21.68 | 34.42 | 41.16 | 89.42 | -- |
| GeneDx Holdings Corp | 267.23m | -83.50m | 2.02bn | 1.00k | -- | 9.85 | -- | 7.54 | -3.17 | -3.17 | 10.11 | 7.45 | 0.6469 | 10.76 | 7.62 | 267,228.00 | -20.21 | -- | -24.54 | -- | 59.48 | 11.50 | -31.25 | -121.10 | 2.27 | -3.72 | 0.2028 | -- | -13.69 | 8.72 | 67.98 | -- | 7.77 | -- |
| National HealthCare Corporation | 1.19bn | 91.85m | 2.09bn | 13.12k | 22.91 | 2.21 | 15.71 | 1.76 | 5.93 | 5.93 | 76.73 | 61.33 | 0.9062 | 107.50 | 11.27 | 90,469.63 | 6.98 | 5.12 | 8.31 | 6.21 | 38.31 | 39.84 | 7.70 | 6.28 | 2.03 | -- | 0.00 | 49.35 | 5.14 | 3.09 | 197.61 | 2.03 | -1.29 | 3.43 |
| NeoGenomics, Inc. | 644.12m | -77.73m | 2.10bn | 2.10k | -- | 2.31 | -- | 3.26 | -0.6152 | -0.6152 | 5.10 | 7.09 | 0.3881 | 14.99 | 4.53 | 306,722.80 | -4.68 | -3.57 | -5.31 | -3.80 | 43.54 | 41.09 | -12.07 | -9.36 | 1.91 | -- | 0.373 | -- | 16.07 | 16.41 | 39.02 | -- | 14.98 | -- |
| Addus Homecare Corporation | 1.13bn | 73.65m | 2.32bn | 6.06k | 29.30 | 2.45 | 26.47 | 2.05 | 4.37 | 4.37 | 67.24 | 52.26 | 1.04 | -- | 10.42 | 187,127.60 | 6.73 | 5.18 | 7.79 | 6.04 | 32.15 | 30.88 | 6.50 | 4.96 | -- | 19.47 | 0.00 | 0.00 | 11.31 | 15.43 | 35.83 | 30.83 | 12.06 | -- |
| Ardent Health Partners Inc | -100.00bn | -100.00bn | 2.47bn | 24.20k | -- | 3.30 | -- | -- | -- | -- | -- | 5.25 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.54 | -- | 0.4845 | -- | 5.45 | -- | -71.47 | -- | -- | -- |
| Concentra Group Holdings Parent Inc | 1.88bn | 172.87m | 2.50bn | 8.90k | 13.37 | 9.02 | 10.10 | 1.34 | 1.47 | 1.47 | 15.70 | 2.18 | -- | -- | -- | 210,774.30 | -- | -- | -- | -- | 27.59 | -- | 9.49 | -- | -- | 5.16 | 0.8311 | -- | 6.60 | -- | 7.93 | -- | -- | -- |
| Alignment Healthcare Inc | 2.47bn | -144.15m | 2.58bn | 1.54k | -- | 22.51 | -- | 1.05 | -0.7606 | -0.7606 | 12.99 | 0.5979 | 3.37 | -- | 20.20 | 1,606,580.00 | -19.72 | -- | -41.65 | -- | 10.45 | -- | -5.85 | -- | -- | -4.96 | 0.6471 | -- | 27.16 | -- | 1.02 | -- | -- | -- |
| Privia Health Group Inc | 1.72bn | 12.82m | 2.73bn | 1.10k | 222.70 | 4.45 | 128.53 | 1.59 | 0.1024 | 0.1024 | 13.71 | 5.13 | 1.61 | -- | 4.52 | 1,557,457.00 | 1.31 | -- | 2.39 | -- | 9.78 | 9.15 | 0.8158 | -2.56 | -- | -- | 0.00 | -- | 22.19 | 20.31 | 368.83 | -- | -12.48 | -- |
| Lifestance Health Group Inc | 1.21bn | -95.29m | 2.83bn | 7.27k | -- | 1.97 | -- | 2.34 | -0.2536 | -0.2536 | 3.20 | 3.76 | 0.5632 | -- | 7.83 | 129,339.70 | -4.45 | -- | -4.98 | -- | -- | -- | -7.90 | -- | -- | -2.31 | 0.164 | -- | 22.82 | -- | 13.59 | -- | -- | -- |
Data as of Nov 12 2024. Currency figures normalised to GeneDx Holdings Corp's reporting currency: US Dollar USD
45.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Casdin Capital LLCas of 01 Aug 2024 | 3.86m | 14.34% |
| Corvex Management LPas of 30 Jun 2024 | 2.47m | 9.18% |
| Goldman Sachs & Co. LLC (Private Banking)as of 30 Sep 2024 | 1.34m | 4.96% |
| Oracle Investment Management, Inc.as of 30 Jun 2024 | 1.11m | 4.11% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 857.36k | 3.18% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 773.83k | 2.87% |
| Gagnon Securities LLCas of 30 Jun 2024 | 573.04k | 2.13% |
| Driehaus Capital Management LLCas of 30 Jun 2024 | 433.64k | 1.61% |
| DWS Investments (UK) Ltd.as of 30 Jun 2024 | 391.49k | 1.45% |
| Geode Capital Management LLCas of 30 Jun 2024 | 347.25k | 1.29% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
